Humaira has over 20 years’ strategic and operational experience in clinical and post-marketing drug safety solutions. As CEO of Qinecsa, Humaira is spearheading a movement to bring together scientific expertise with technology and create world-leading solutions that address the challenges faced by the pharmacovigilance industry and advance drug safety solutions to the next level. Prior to 2022 Humaira led a number of global pharmacovigilance businesses, delivering growth through customer excellence during the implementation and management of PV operational solutions for many of the world's largest pharmaceutical companies. Humaira has a bachelor's degree in Medicinal Biochemistry from Royal Holloway, University of London. She is frequently invited to lecture, having presented on a range of pharmacovigilance topics at industry and academic events in the US, EU, and Asia, and has participated on a number of Global PV forums focusing on technology, sourcing, and process enablement.